News

Articles

Browse events, publications and articles relating to cell culture and ExcellGene's work.

2021

• ExcellGene to Manufacture SARS-CoV-2 Trimeric Omicron Spike Protein, Optimized for Subunit Vaccine, Diagnostic and Drug Development
• Publication: Naming CHO Cells for Bio-manufacturing
• Twenty Years of Scientific Innovation at ExcellGene
• Video: From DNA to Therapeutic Protein in CHO Cells
• White Paper: Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing
• New career opportunities available in cell culture!
• Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens (Summary)

2020

• SARS-CoV-2 trimeric spike proteins, now available in grams.
• Subunit Vaccine Production in CHO cells: Development of an Efficacious Ebola Virus Vaccine Candidate
• White Paper: CHO Quasispecies – Implications for Manufacturing Processes Now Available
• Talks: Single-Use Bioreactors and Disposable Process Materials: How-To and Issues @ Disposable Solutions Berlin, Feb 19

2019

• @ BioProduction 2019: Smart Strategies to Enhance Productivity, Improve Titers, Cell Culture Performance and Product Quality
• White Paper: Cloning of CHO Cells, Productivity and Genetic Stability, Best Paper Award, Keynote Lecture on CHO

2018

• A New Ebola Vaccine: ExcellGene in a Euro-Swiss Initiative
• The Future of Transient Gene Expression, Keynote and Podcast at PEGS 2018
• Transient Gene Expression: Paper Submissions Welcome
• Better Media and Feeds for Higher CHO Yield